tm logo
NATIVE GENE CONTROL
WITHDRAWN

on 31 Dec 1969

Last Applicant/ Owned by

OMEGA THERAPEUTICS INC.

140 First Street, Suite 501 Cambridge MA 02141

US

Serial Number

2185257 filed on 15th Apr 2022

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

NATIVE GENE CONTROL

Trademark usage description

pharmaceutical agents that target dna structure to treat various diseases, namely, monogenic diseases, cancer, infectious disease, immune disease, hem Read More

Classification Information


Class [005]
Pharmaceutical agents that target DNA structure to treat various diseases, namely, monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease.


Classification kind code

11

Mark Details


Serial Number

2185257

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 05th Sep 2023
Search Recorded
Submitted for opposition 20
on 05th Sep 2023
Examiner's First Report
Submitted for opposition 135
on 22nd Jun 2023
Amendment to Application
Submitted for opposition 256
on 13th Mar 2023
Notification of Possible Opposition Sent
Submitted for opposition 48
on 27th Jun 2022
Agent Changed
Submitted for opposition 257
on 12th May 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 11th May 2022
Created
Submitted for opposition 31
on 11th May 2022
Formalized
Submitted for opposition 30
on 15th Apr 2022
Filed
Submitted for opposition 228
on 15th Apr 2022
International Registration